kanamycin a has been researched along with Cochlear Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brough, DE; Hsu, C; Kraft, S; Staecker, H | 1 |
| Johnson, SB; Santi, PA; Schmitz, HM | 1 |
| Hirose, K; Li, SZ; Ohlemiller, KK; Ransohoff, RM | 1 |
| Heeringa, AN; Raphael, Y; Shore, SE; Stefanescu, RA | 1 |
| GREGG, JB; HOSKINS, JH | 1 |
| Forge, A; Nevill, G; Taylor, RR | 1 |
| Campbell, S; Forge, A; Hume, CR; Oesterle, EC; Taylor, RR | 1 |
7 other study(ies) available for kanamycin a and Cochlear Diseases
| Article | Year |
|---|---|
Atoh1 induces auditory hair cell recovery in mice after ototoxic injury.
Topics: Animals; Anti-Bacterial Agents; Basic Helix-Loop-Helix Transcription Factors; Cochlear Diseases; Diuretics; Furosemide; Genetic Therapy; Hair Cells, Auditory; Hearing Loss, Sensorineural; Kanamycin; Mice; Mice, Inbred C57BL; Regeneration | 2013 |
Kanamycin-furosemide ototoxicity in the mouse cochlea: a 3-dimensional analysis.
Topics: Animals; Cochlea; Cochlear Diseases; Disease Models, Animal; Female; Furosemide; Hair Cells, Auditory; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Injections, Subcutaneous; Kanamycin; Mice; Mice, Inbred CBA; Microscopy, Confocal; Organ of Corti; Radiography; Random Allocation; Reference Values; Sensitivity and Specificity; Ultrasonography | 2014 |
Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide.
Topics: Animals; Anti-Bacterial Agents; Cochlea; Cochlear Diseases; CX3C Chemokine Receptor 1; Disease Models, Animal; Drug Synergism; Ear, Inner; Evoked Potentials, Auditory, Brain Stem; Furosemide; Hair Cells, Auditory, Outer; Heterozygote; Inflammation; Kanamycin; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Receptors, Chemokine | 2014 |
Altered vesicular glutamate transporter distributions in the mouse cochlear nucleus following cochlear insult.
Topics: Animals; Cell Count; Cochlear Diseases; Cochlear Nucleus; Deafness; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Functional Laterality; Immunohistochemistry; Kanamycin; Mice, Inbred C57BL; Neurons; Spiral Ganglion; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2 | 2016 |
Cochlear and vestibular injury from kanamycin.
Topics: Anti-Bacterial Agents; Cochlea; Cochlear Diseases; Disease; Humans; Kanamycin; Vestibular Diseases; Vestibule, Labyrinth | 1959 |
Rapid hair cell loss: a mouse model for cochlear lesions.
Topics: Age Factors; Amikacin; Animals; Anti-Bacterial Agents; Bumetanide; Cell Death; Cell Survival; Cochlear Diseases; Disease Models, Animal; Diuretics; Fluorescent Dyes; Gentamicins; Hair Cells, Auditory, Outer; Kanamycin; Mice; Mice, Inbred CBA; Pyridinium Compounds; Quaternary Ammonium Compounds; Stria Vascularis | 2008 |
Sox2 and JAGGED1 expression in normal and drug-damaged adult mouse inner ear.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Biomarkers; Calcium-Binding Proteins; Chickens; Cochlear Diseases; Disease Models, Animal; Diuretics; Furosemide; Intercellular Signaling Peptides and Proteins; Jagged-1 Protein; Kanamycin; Membrane Proteins; Mice; Mice, Inbred CBA; Organ of Corti; Serrate-Jagged Proteins; SOXB1 Transcription Factors; Time Factors | 2008 |